These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22871711)

  • 1. Stealing fire: a retrospective survey of biotech patent claims in the wake of Mayo v. Prometheus.
    Haanes EJ; Cànaves JM
    Nat Biotechnol; 2012 Aug; 30(8):758-60. PubMed ID: 22871711
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact of Myriad and Mayo: will advancements in the biological sciences be spurred or disincentivized? (Or was biotech patenting not complicated enough?).
    Gordon J
    Cold Spring Harb Perspect Med; 2014 Dec; 5(5):a020917. PubMed ID: 25502748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. University biotech patenting 2013.
    Huggett B; Paisner K
    Nat Biotechnol; 2014 Jun; 32(6):512. PubMed ID: 24911487
    [No Abstract]   [Full Text] [Related]  

  • 4. Defining the scope of biotech patent claims.
    McGough KJ
    Biotechnology (N Y); 1995 Apr; 13(4):318-9. PubMed ID: 9678945
    [No Abstract]   [Full Text] [Related]  

  • 5. Industry reels as Prometheus falls and Myriad faces further reviews.
    Fox JL
    Nat Biotechnol; 2012 May; 30(5):373-4. PubMed ID: 22565942
    [No Abstract]   [Full Text] [Related]  

  • 6. Utility in biotech patent applications.
    Linck NJ; Chambers SA
    Biotechnology (N Y); 1995 Sep; 13(9):962-4. PubMed ID: 9678953
    [No Abstract]   [Full Text] [Related]  

  • 7. Biotech leaders give patent office a litany of complaints.
    Marshall E
    Science; 1994 Oct; 266(5185):537. PubMed ID: 7939696
    [No Abstract]   [Full Text] [Related]  

  • 8. Patent drop reveals pressures on industry.
    Lawrence S
    Nat Biotechnol; 2004 Aug; 22(8):930-1. PubMed ID: 15286630
    [No Abstract]   [Full Text] [Related]  

  • 9. US court bolsters biotech patent protection.
    Harrison C
    Nat Biotechnol; 2011 Aug; 29(8):672-3. PubMed ID: 21822224
    [No Abstract]   [Full Text] [Related]  

  • 10. The prevalence of patent interferences in gene technology.
    Merz JF; Henry MR
    Nat Biotechnol; 2004 Feb; 22(2):153-4. PubMed ID: 14755283
    [No Abstract]   [Full Text] [Related]  

  • 11. The obviousness rejection as a barrier to biotech patent prosecution.
    Wang SJ
    Nat Biotechnol; 2009 Dec; 27(12):1125-6. PubMed ID: 20010590
    [No Abstract]   [Full Text] [Related]  

  • 12. Unsettled expectations: how recent patent decisions affect biotech.
    Simon BM; Scott CT
    Nat Biotechnol; 2011 Mar; 29(3):229-30. PubMed ID: 21390025
    [No Abstract]   [Full Text] [Related]  

  • 13. The challenges of joint performance to method patents.
    Chen FC
    Expert Opin Ther Pat; 2017 Apr; 27(4):393-399. PubMed ID: 28266880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patent reform acts ugly.
    Nat Biotechnol; 2007 Nov; 25(11):1187. PubMed ID: 17989652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patent first, ask questions later: morality and biotechnology in patent law.
    Bagley MA
    William Mary Law Rev; 2003 Dec; 45(2):469-547. PubMed ID: 15570677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supreme Court boosts licensees in biotech patent battles.
    Waltz E
    Nat Biotechnol; 2007 Mar; 25(3):264-5. PubMed ID: 17344866
    [No Abstract]   [Full Text] [Related]  

  • 17. Intellectual property. Decision on NFkappaB patent could have broad implications for biotech.
    Garber K
    Science; 2006 May; 312(5775):827. PubMed ID: 16690824
    [No Abstract]   [Full Text] [Related]  

  • 18. Intellectual property. Biotech feels a chill from changing U.S. patent rules.
    Servick K
    Science; 2014 Jul; 345(6192):14-5. PubMed ID: 24994626
    [No Abstract]   [Full Text] [Related]  

  • 19. Prometheus bound, but myriad loose ends: amid new legal battles over BRCA tests, technology may resolve what the courts have not.
    Nelson B
    Cancer Cytopathol; 2013 Oct; 121(10):535-6. PubMed ID: 24130100
    [No Abstract]   [Full Text] [Related]  

  • 20. Proposed changes to patent code loom over biotech industry.
    Coombs A
    Nat Biotechnol; 2007 Dec; 25(12):1333-4. PubMed ID: 18066010
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.